Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo

被引：0
|
作者：
Zhiqiang Zhang
Chunling Ma
Peng Li
Min Wu
Shengnan Ye
Liwu Fu
Jianhua Xu
机构：
[1] Fujian Medical University,Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute
[3] The First Affiliated Hospital of Fujian Medical University,undefined
来源：
Cell Communication and Signaling | / 17卷
关键词：
FW-04-806; ABCB1 transporter; ABCG2 transporter; Multiple drug resistance; Molecular docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
    Ke Yang
    Yifan Chen
    Kenneth Kin Wah To
    Fang Wang
    Delan Li
    Likun Chen
    Liwu Fu
    Experimental & Molecular Medicine, 2020, 52 : 989 - 990
  • [32] Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
    Feng, Sen-Ling
    Luo, Hai-Bin
    Cai, Liang
    Zhang, Jie
    Wang, Dan
    Chen, Ying-Jiang
    Zhan, Huan-Xing
    Jiang, Zhi-Hong
    Xie, Ying
    JOURNAL OF GINSENG RESEARCH, 2020, 44 (02) : 247 - 257
  • [33] Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
    Zhang, Yuchen
    Li, Cheukfai
    Xia, Chenglai
    To, Keneth Kin Wah
    Guo, Zhixing
    Ren, Chongyang
    Wen, Lingzhu
    Wang, Fang
    Fu, Liwu
    Liao, Ning
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [34] Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
    Yuchen Zhang
    Cheukfai Li
    Chenglai Xia
    Keneth Kin Wah To
    Zhixing Guo
    Chongyang Ren
    Lingzhu Wen
    Fang Wang
    Liwu Fu
    Ning Liao
    Cell Communication and Signaling, 20
  • [35] Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
    Tiwari, Amit K.
    Sodani, Kamlesh
    Wang, Si-Rong
    Kuang, Ye-Hong
    Ashby, Charles R., Jr.
    Chen, Xiang
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (02) : 153 - 161
  • [36] Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments
    To, Kenneth K. W.
    Hu, Miao
    Tomlinson, Brian
    PHARMACOGENOMICS, 2014, 15 (08) : 1091 - 1104
  • [37] Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines
    Wu, Chung-Pu
    Lusvarghi, Sabrina
    Wang, Jyun-Cheng
    Hsiao, Sung-Han
    Huang, Yang-Hui
    Hung, Tai-Ho
    Ambudkar, Suresh V.
    MOLECULAR PHARMACEUTICS, 2019, 16 (07) : 3040 - 3052
  • [38] Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
    Nazari, Somayeh
    Mosaffa, Fatemeh
    Poustforoosh, Alireza
    Mortazavi, Motahareh
    Saso, Luciano
    Firuzi, Omidreza
    Moosavi, Fatemeh
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 484
  • [39] Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
    Wu, Chung-Pu
    Li, Yen-Ching
    Murakami, Megumi
    Hsiao, Sung-Han
    Lee, Yun-Chieh
    Huang, Yang-Hui
    Chang, Yu-Tzu
    Hung, Tai-Ho
    Wu, Yu-Shan
    Ambudkar, Suresh V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [40] Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening
    Tournier, Nicolas
    Valette, Heric
    Peyronneau, Marie-Anne
    Saba, Wadad
    Goutal, Sebastien
    Kuhnast, Bertrand
    Dolle, Frederic
    Scherrmann, Jean-Michel
    Cisternino, Salvatore
    Bottlaender, Michel
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (03) : 415 - 423
12345